NovoCure Ltd - Common Stock (NVCR)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / Common Stock
Shares outstanding
112M
Number of holders
344
Total 13F shares, excl. options
74.2M
Shares change
+716K
Total reported value, excl. options
$12.8B
Value change
+$247M
Put/Call ratio
0.73
Number of buys
204
Number of sells
-117
Price
$173.04

Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2020

415 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2020.
NovoCure Ltd - Common Stock (NVCR) has 344 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 74.2M shares of 112M outstanding shares and own 66.22% of the company stock.
Largest 10 shareholders include FMR LLC (9.63M shares), BAILLIE GIFFORD & CO (8.26M shares), Capital International Investors (8.26M shares), VANGUARD GROUP INC (8.24M shares), Capital World Investors (7.75M shares), BlackRock Inc. (5.8M shares), STATE STREET CORP (1.93M shares), CREDIT SUISSE AG/ (1.45M shares), MORGAN STANLEY (1.35M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.24M shares).
This table shows the top 344 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.